Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TASTE: Customized vs Standard Adjuvant Therapy in NSCLC
NCT00775385Phase 3Completed
- Sponsor
- IFCT
- Start
- Apr 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by IFCT. Started Apr 2009; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00775385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775385.